Full Text View
Tabular View
No Study Results Posted
Related Studies
Anti-Interleukin-5 Antibody to Treat Hypereosinophilic Syndrome
This study has been completed.
Study NCT00017862   Information provided by National Institutes of Health Clinical Center (CC)

First Received on June 15, 2001.   Last Updated on March 3, 2008   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Hypereosinophilic Syndrome
Additional conditions recognized in this trial
Eosinophilic Esophagitis
More general conditions related to this trial
Digestive System Diseases
Eosinophilia
Esophageal Diseases
Esophagitis
Gastroenteritis
Gastrointestinal Diseases
Hematologic Diseases
Hypersensitivity
Hypersensitivity, Immediate
Immune System Diseases
Leukocyte Disorders
Interventions listed in this trial
SCH55700
Additional drug interventions recognized in this trial
Antibodies
More general drug interventions related to this trial
Immunologic Factors
Pharmacologic Actions
Physiological Effects of Drugs
Sponsors listed in this trial
National Institute of Allergy and Infectious Diseases (NIAID)


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services